Inari Medical Q1 2024 GAAP EPS $(0.42) Misses $(0.16) Estimate, Sales $143.200M Beat $138.373M Estimate
Author: Benzinga Newsdesk | April 30, 2024 04:27pm
Inari Medical (NASDAQ:
NARI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.16) by 162.5 percent. The company reported quarterly sales of $143.200 million which beat the analyst consensus estimate of $138.373 million by 3.49 percent. This is a 23.27 percent increase over sales of $116.167 million the same period last year.
Posted In: NARI